Showing results (51-60 of 378) with videos related to

Sort By:
Pageof 38
Transplantation|April 28, 2012
Immunological issues in clinical composite tissue allotransplantation: where do we stand today?Emmanuel Morelon, Jean Kanitakis, Palmina Petruzzo
Transplantation|May 18, 2012
Vascularized composite allotransplantation: a member of the transplant family?Stefan Schneeberger, Emmanuel Morelon, Luis Landin, et al.
Disease Models & Mechanisms|February 26, 2020
Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosisLynda Aoudjehane, Jérémie Gautheron, Wilfried Le Goff, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2022
Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE studyFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
Presse Medicale (Paris, France : 1983)|May 20, 2008
[Rules for allocation of livers for transplantation]Christian Jacquelinet, Benoît Audry, Fabienne Pessione, et al.
Leukemia & Lymphoma|June 30, 2004
Autoimmune pancytopenia as an early complication of liver transplantation: report of one caseCharikleia Kelaïdi, Alexandru Buturuga, Bertrand Dousset, et al.
Journal of the American Academy of Dermatology|June 20, 2006
Scurvy in liver transplant patientsHéloïse Hatuel, Marc Buffet, Christine Mateus, et al.
Journal of Hepatology|August 12, 2009
Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease?Valérie Perut, Filoména Conti, Olivier Scatton, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 22, 2019
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 YearsFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
Journal of Hepatology|August 19, 2015
Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrenceAlexie Bosch, Jérôme Dumortier, Delphine Maucort-Boulch, et al.
Pageof 38